Session: BM1
Platform Technologies & Biomaterials

Chair

Julie Phillippi, PhD and Carlijn Bouten, PhD

Time

08:30 - 09:00 on Saturday, 10th of September 2016

Venue

Max Bell Auditorium

08:30

A Synthetic Macromolecule to Reverse Heparin Anticoagulation and Profibrinolytic Activity without Altering Clot Morphology

Manu Thomas Kalathottukaren (University of British Columbia), Libin Abraham (University of British Columbia), Rajesh Shenoi (University of British Columbia), Federico Rosell (University of British Columbia), Charles Haynes (University of British Columbia), Jayachandran Kizhakkedathu (University of British Columbia)
08:45

A Hybrid Biomaterials Platform for Neovascularization in Engineered Human iPSC-derived Cardiac Tissue

Fabiola Munarin (Brown University), Kareen Coulombe (Brown University)